Discovery of G2019S-Selective Leucine Rich Repeat Protein Kinase 2 inhibitors with in vivo efficacy-Reference-Cited by-同舟云学术

Discovery of G2019S-Selective Leucine Rich Repeat Protein Kinase 2 inhibitors with in vivo efficacy

Published:2022-02 Issue: Volume:229 Page:114080
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Leśniak Robert K.^ORCID,Nichols R. Jeremy,Schonemann Marcus,Zhao Jing,Gajera Chandresh R.^ORCID,Fitch William L.,Lam Grace,Nguyen Khanh C.,Smith Mark,Montine Thomas J.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference47 articles.

1. Substrate reduction therapy for GBA1-associated Parkinsonism: are we betting on the wrong mouse?;Sidransky;Mov. Disord.,2020

2. LRRK2 activation in idiopathic Parkinson's disease;Di Maio;Sci. Transl. Med.,2018

3. Effect of selective LRRK2 kinase inhibition on nonhuman primate lung;Fuji;Sci. Transl. Med.,2015

4. Characterization of the onset, progression, and reversibility of morphological changes in mouse lung after pharmacological inhibition of leucine-rich kinase 2 kinase activity;Bryce;J. Pharmacol. Exp. Therapeut.,2021

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease: a patent review of the literature to date;Expert Opinion on Therapeutic Patents;2024-07-19

2. In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson’s;2024-05-06

3. Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases;ACS Chemical Neuroscience;2024-04-22

4. G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage;npj Parkinson's Disease;2024-03-01

5. Stereoselective Amine Synthesis Mediated by a Zirconocene Hydride to Accelerate a Drug Discovery Program;The Journal of Organic Chemistry;2024-02-29